AnaptysBio
ANAB
ANAB
121 hedge funds and large institutions have $1.85B invested in AnaptysBio in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 129 → 121 (-8)
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
35% less capital invested
Capital invested by funds: $2.85B → $1.85B (-$1B)
Holders
121
Holding in Top 10
3
Calls
$11.7M
Puts
$7.74M
Top Buyers
| 1 | +$63.5M | |
| 2 | +$15.7M | |
| 3 | +$12.1M | |
| 4 |
Millennium Management
New York
|
+$10.6M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$8.68M |
Top Sellers
| 1 | -$28.6M | |
| 2 | -$26.2M | |
| 3 | -$17M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$13.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.3M |